Hospitals reduced central line-associated bloodstream infections by 50% between 2008 and 2016, according to a new progress summary by the Centers for Disease Control and Prevention. The report also shows progress by hospitals in reducing other healthcare-associated infections, including catheter-associated urinary tract, surgical site, methicillin-resistant staphylococcus aureus and Clostridium difficile infections. The AHA’s Health Research & Educational Trust affiliate has been working with the CDC to reduce CLABSI, CAUTI, C difficile and MRSA infections in targeted acute care hospitals. HRET also has worked with the Agency for Healthcare Research and Quality’s Comprehensive Unit Based Safety Program to prevent CLABSI and CAUTI infections, and with the Centers for Medicare & Medicaid Services’ Hospital Improvement Innovation Networks to continue to reduce hospital-acquired conditions in the Medicare program.

Related News Articles

Headline
The AHA the week of July 8 released its Quality Collective Report, which explores quality, safety and performance improvement strategies and insights from…
Headline
In a new “Safety Speaks” conversation, Harry S. Smith, board chair of Valley Health System and member of the AHA Committee on Governance, discusses how Valley…
Headline
The Administration for Strategic Preparedness and Response June 25 announced a flu pandemic preparedness and response strategy in response to the threat of…
Headline
The Centers for Disease Control and Prevention June 25 issued a Health Alert Network Health Advisory about an increased risk of dengue virus infections in the…
Headline
“Safety Speaks” is a new Advancing Health series where hospital and health system leaders share successes from their organizations’ patient safety efforts. In…
Headline
The Food and Drug Administration last week granted enforcement discretion for the use of conjunctival swabs by laboratories as part of human testing for H5N1…